Full Professor at Dept. of Oncology, University of Torino, and Director of the Laboratory of Molecular Oncology at the Candiolo Cancer Institute-IRCCS, Candiolo, Italy. As a postdoc at the Johns Hopkins University (USA), in the group of Bert Vogelstein, he performed the first comprehensive mutational profile of protein and lipid kinases in colorectal cancers (CRC). As an independent investigator he translated these findings into clinical practice by unveiling the molecular landscape of response and resistance to EGFR blockade in CRC. Prof. Bardelli is currently studying how the emergence and evolution of drug resistant clones can be restrained to improve the efficacy of anticancer agents.
« Go Back